Related references
Note: Only part of the references are listed.Overview of the 2022 WHO Classification of Pituitary Tumors
Sylvia L. Asa et al.
ENDOCRINE PATHOLOGY (2022)
Predictive model of surgical remission in acromegaly: age, presurgical GH levels and Knosp grade as the best predictors of surgical remission
M. Araujo-Castro et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2021)
A Pituitary Society update to acromegaly management guidelines
Maria Fleseriu et al.
PITUITARY (2021)
Multicenter, Observational Study of Lanreotide Autogel for the Treatment of Patients with Acromegaly in Routine Clinical Practice in Germany, Austria and Switzerland
Sylvere Stoermann et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2021)
Predictors of postoperative biochemical remission in acromegaly
Shun Yao et al.
JOURNAL OF NEURO-ONCOLOGY (2021)
Predictors for Remission after Transsphenoidal Surgery in Acromegaly: A Dutch Multicenter Study
Eva C. Coopmans et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)
Pasireotide in the Personalized Treatment of Acromegaly
Manel Puig-Domingo et al.
FRONTIERS IN ENDOCRINOLOGY (2021)
Clinical and Radiological Predictors of Biochemical Response to First-Line Treatment With Somatostatin Receptor Ligands in Acromegaly: A Real-Life Perspective
Federica Nista et al.
FRONTIERS IN ENDOCRINOLOGY (2021)
T2-weighted magnetic resonance imaging as a novel predictor of surgical remission in newly diagnosed pituitary macroadenomas presenting as acromegaly
Enes Akkaya et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2021)
Association of different pathologic subtypes of growth hormone producing pituitary adenoma and remission in acromegaly patients: a retrospective cohort study
Maryam Dehghani et al.
BMC ENDOCRINE DISORDERS (2021)
COMPARATIVE EFFICACY OF MEDICAL TREATMENT FOR ACROMEGALY: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS OF INTEGRATED RANDOMIZED TRIALS AND OBSERVATIONAL STUDIES
Nidan Qiao et al.
ENDOCRINE PRACTICE (2020)
How to Classify Pituitary Neuroendocrine Tumors (PitNET)s in 2020
Jacqueline Trouillas et al.
CANCERS (2020)
Pituitary tumours - a large retrospective single-centre study of over 2300 cases. Experience of a tertiary reference centre
Beata Rak et al.
ENDOKRYNOLOGIA POLSKA (2020)
T2-signal intensity, SSTR expression, and somatostatin analogs efficacy predict response to pasireotide in acromegaly
Eva C Coopmans et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2020)
Multivariable Prediction Model for Biochemical Response to First-Generation Somatostatin Receptor Ligands in Acromegaly
Eva C. Coopmans et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
Prognostic factors of biochemical remission after transsphenoidal surgery for acromegaly: a structured review
Nidhi Agrawal et al.
PITUITARY (2020)
Multidisciplinary management of acromegaly: A consensus
Andrea Giustina et al.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2020)
Gender differences and temporal trends over two decades in acromegaly: a single center study in 112 patients
Adriana G. Ioachimescu et al.
ENDOCRINE (2020)
Systemic Complications of Acromegaly and the Impact of the Current Treatment Landscape: An Update
Monica R. Gadelha et al.
ENDOCRINE REVIEWS (2019)
Growth hormone and prolactin-staining tumors causing acromegaly: a retrospective review of clinical presentations and surgical outcomes
Jonathan Rick et al.
JOURNAL OF NEUROSURGERY (2019)
Diagnostics and treatment of acromegaly - updated recommendations of the Polish Society of Endocrinology
Marek Bolanowski et al.
ENDOKRYNOLOGIA POLSKA (2019)
Potential antitumour activity of pasireotide on pituitary tumours in acromegaly
Eva C. Coopmans et al.
LANCET DIABETES & ENDOCRINOLOGY (2019)
Shrinkage of pituitary adenomas with pasireotide reply
Eva C. Coopmans et al.
LANCET DIABETES & ENDOCRINOLOGY (2019)
Mortality in acromegaly decreased in the last decade: a systematic review and meta-analysis
F. Bolfi et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2019)
Pasireotide Responsiveness in Acromegaly Is Mainly Driven by Somatostatin Receptor Subtype 2 Expression
Ammar Muhammad et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
Associations of Ki-67 Labeling Index with Clinical and Paraclinical Features of Growth Hormone-Secreting Pituitary Adenomas: A Single Center Report from Iran
Shahrzad Mohseni et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM (2019)
Markers of proliferation and invasiveness in somatotropinomas
Agata Baldys-Waligorska et al.
ENDOKRYNOLOGIA POLSKA (2018)
Age- and Sex-Specific Differences as Predictors of Surgical Remission Among Patients With Acromegaly
Se Hee Park et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)
A Consensus Statement on acromegaly therapeutic outcomes
Shlomo Melmed et al.
NATURE REVIEWS ENDOCRINOLOGY (2018)
Predictors of surgical outcome and early criteria of remission in acromegaly
Ximene Antunes et al.
ENDOCRINE (2018)
In Vitro Head-to-Head Comparison Between Octreotide and Pasireotide in GH-Secreting Pituitary Adenomas
Federico Gatto et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)
Long-Term Endocrine Outcomes Following Endoscopic Endonasal Transsphenoidal Surgery for Acromegaly and Associated Prognostic Factors
Harish Babu et al.
NEUROSURGERY (2017)
The 2017 World Health Organization classification of tumors of the pituitary gland: a summary
M. Beatriz S. Lopes
ACTA NEUROPATHOLOGICA (2017)
Factors predicting pasireotide responsiveness in somatotroph pituitary adenomas resistant to first-generation somatostatin analogues: an immunohistochemical study
Donato Iacovazzo et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2016)
Growth hormone tumor histological subtypes predict response to surgical and medical therapy
Katja Kiseljak-Vassiliades et al.
ENDOCRINE (2015)
An analysis of granulation patterns, MIB-1 proliferation indices and p53 expression in 101 patients with acromegaly
Sauradeep Sarkar et al.
ACTA NEUROCHIRURGICA (2014)
Endocrinological outcomes following endoscopic and microscopic transsphenoidal surgery in 113 patients with acromegaly
Sauradeep Sarkar et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2014)
ACROMEGALY: ASSESSING THE DISORDER AND NAVIGATING THE THERAPEUTIC OPTIONS FOR TREATMENT
Shlomo Melmed et al.
ENDOCRINE PRACTICE (2014)
Factors Associated with Biochemical Remission after Microscopic Transsphenoidal Surgery for Acromegaly
Hai Sun et al.
JOURNAL OF NEUROLOGICAL SURGERY PART B-SKULL BASE (2014)
Ki-67 is a predictor of acromegaly control with octreotide LAR independent of SSTR2 status and relates to cytokeratin pattern
Leandro Kasuki et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2013)
Expression of SSTR2a, but not of SSTRs 1, 3, or 5 in Somatotroph Adenomas Assessed by Monoclonal Antibodies Was Reduced by Octreotide and Correlated With the Acute and Long-Term Effects of Octreotide
Olivera Casar-Borota et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Endoscopic vs Microsurgical Transsphenoidal Surgery for Acromegaly: Outcomes in a Concurrent Series of Patients Using Modern Criteria For Remission
Robert M. Starke et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Treatment of acromegaly by endoscopic transsphenoidal surgery: surgical experience in 214 cases and cure rates according to current consensus criteria
Derya Burcu Hazer et al.
JOURNAL OF NEUROSURGERY (2013)
Growth hormone granulation pattern and somatostatin receptor subtype 2A correlate with postoperative somatostatin receptor ligand response in acromegaly: a large single center experience
Jessica Brzana et al.
PITUITARY (2013)
Intensity of pituitary adenoma on T2-weighted magnetic resonance imaging predicts the response to octreotide treatment in newly diagnosed acromegaly
Ansgar Heck et al.
CLINICAL ENDOCRINOLOGY (2012)
The characteristics of acromegalic patients with hyperprolactinemia and the differences in patients with merely GH-secreting adenomas: clinical analysis of 279 cases
Min Wang et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2012)
Endoscopic Transsphenoidal Surgery for Acromegaly: Remission Using Modern Criteria, Complications, and Predictors of Outcome
John A. Jane et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Magnetic Resonance Imaging as a Predictor of Response to Somatostatin Analogs in Acromegaly after Surgical Failure
Manel Puig-Domingo et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Surgical debulking of pituitary macroadenomas causing acromegaly improves control by lanreotide
N. Karavitaki et al.
CLINICAL ENDOCRINOLOGY (2008)
Prognostic significance of the Ki-67 labeling index in growth hormone-secreting pituitary adenomas
A. Fusco et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Partial surgical removal of growth hormone-secreting pituitary tumors enhances the response to somatostatin analogs in acromegaly
A Colao et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Gross total resection or debulking of pituitary adenomas improves hormonal control of acromegaly by somatostatin analogs
P Petrossians et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2005)
The efficacy of octreotide LAR (long acting release) treatment in patients with somatotropinoma, and mixed pituitary tumours
R Wasko et al.
PHARMACY WORLD & SCIENCE (2004)
Comparison of growth hormone-producing and non-growth hormone-producing pituitary adenomas: Imaging characteristics and pathologic correlation
A Hagiwara et al.
RADIOLOGY (2003)
Transsphenoidal surgery for acromegaly in Wales: Results based on stringent criteria of remission
P De et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Evolving criteria for post-operative biochemical remission of acromegaly: can we achieve a definitive cure? An audit of surgical results on a large series and a review of the literature
G Minniti et al.
ENDOCRINE-RELATED CANCER (2003)
A retrospective hormonal and immunohistochemical evaluation of 47 acromegalic patients: Prognostic value of preoperative plasma prolactin
L De Marinis et al.
HORMONE AND METABOLIC RESEARCH (2002)
Share Paper
